Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer

NCT05628610 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

130

Enrollment

OTHER_GOV

Sponsor class

Conditions

Esophageal Cancer

Interventions

DRUG: Tislelizumab
RADIATION: Radiation
DRUG: Paclitaxel
DRUG: Platinum: cisplatin, carboplatin, naidaplatin and other platinum drugs

Sponsor

Fujian Cancer Hospital